The Charcot‐Marie‐Tooth syndrome: perceptions of disability and projected use of DNA diagnostic tests
- 1 October 1992
- journal article
- Published by Wiley in Clinical Genetics
- Vol. 42 (4) , 161-163
- https://doi.org/10.1111/j.1399-0004.1992.tb03231.x
Abstract
The Charcot‐Marie‐Tooth group of disorders cause significant morbidity in a proportion of the individuals affected. We have shown that there is a significant correlation between the objective neurological assessment of their dysfunction and the individual's subjective perception of their disability. We have also documented the observation that individuals expressing an intention to use prenatal DNA diagnostic services and terminate an “affected” fetus are more severely affected by their disorder than those who would not, or who were unsure about their use of molecular genetic testing.Keywords
This publication has 8 references indexed in Scilit:
- Charcot-Marie-Tooth disease type 1a (CMT1a): evidence for trisomy of the region p11.2 of chromosome 17 in south Wales families.Journal of Medical Genetics, 1992
- Single‐gene neurological disorders in south wales: An epidemiological studyAnnals of Neurology, 1991
- DNA duplication associated with Charcot-Marie-Tooth disease type 1ACell, 1991
- Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a)Neuromuscular Disorders, 1991
- Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosisClinical Genetics, 1990
- UPTAKE OF PRESYMPTOMATIC PREDICTIVE TESTING FOR HUNTINGTON'S DISEASEThe Lancet, 1989
- At‐risk Persons' attitudes toward presymptomatic and prenatal testing of Huntington disease in MichiganAmerican Journal of Medical Genetics, 1987
- Human diabetic endoneurial sorbitol, fructose, and myo‐inositol related to sural nerve morphometryAnnals of Neurology, 1980